Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis <scp>C</scp> patients
Luisa Ronzoni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Maria Domenica Cappellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alessio Aghemo, Laura Porretti(Ospedale Maggiore), Maria Grazia Rumi(University of Milan), M. Colombo(University of Milan), Sara Monico(University of Milan), G.M. Prati(University of Milan), Alessandra Colancecco(University of Milan)
Cited by 11
Related Papers
Thalassaemia
|The Lancet|2017|763
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539